NYMOX PHARMACEUTICAL CORPORATION Diluted Earnings Loss Per Share
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Diluted Earnings Loss Per Share of -$0.02 per share for the 3-month period ending 2022-09-30, per its 6-K/A filed 2022-11-16.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShare · last filed 2022-11-16
- NYMOX PHARMACEUTICAL CORPORATION diluted earnings loss per share for the quarter ending 2022-09-30 was -$0.02.
- NYMOX PHARMACEUTICAL CORPORATION diluted earnings loss per share for the quarter ending 2022-06-30 was $0.01.
- NYMOX PHARMACEUTICAL CORPORATION diluted earnings loss per share for the quarter ending 2021-09-30 was -$0.04.
- NYMOX PHARMACEUTICAL CORPORATION diluted earnings loss per share for the quarter ending 2021-06-30 was -$0.05.
| Period end | Diluted Earnings Loss Per Share 3 month | Diluted Earnings Loss Per Share 6 month | Diluted Earnings Loss Per Share 9 month |
|---|---|---|---|
| 2022-09-30 | -$0.02 6-K/A · filed 2022-11-16 | -$0.06 6-K/A · filed 2022-11-16 | |
| 2022-06-30 | $0.01 6-K · filed 2022-08-15 | -$0.04 6-K · filed 2022-08-15 | |
| 2021-09-30 | -$0.04 6-K/A · filed 2022-11-16 | -$0.12 6-K/A · filed 2022-11-16 | |
| 2021-06-30 | -$0.05 6-K · filed 2022-08-15 | -$0.08 6-K · filed 2022-08-15 |